Gapping up
In reaction to strong earnings/guidance:
- AMKR +17.7%, AN +9.8%, FLDM +8.1%, JLL +7.2%, HAS +5.8%, RNG +4.5%, OMF +4.5%, BHF +3.3%, BURL +2.9% (guides higher), VOYA +2.7%, XPO +2.5%, STE +2%, EXC +1.8%, USFD +1.7%, CRL +1.6%, OMC +1.4%, DBD +1.4%, D +1%
M&A news:
- S +63.8% (A Judge is expected to rule in favor Sprint (S) / TMUS merger, according to NY Times); TMUS +7.5%
- SYNC +11.1% (Synacor and Qumu agree to merger in an all stock transaction)
- QUMU +11.1% (Synacor and Qumu agree to merger in an all stock transaction)
Other news:
- LKCO +3.7% (selected as provider of HP Map Service for Ford China's (F) autonomous driving project)
- INCY +2.2% (receives Priority Review of NDA for Capmatinib)
- VALE +1.6% (production and sales in 4Q19 and 2019)
- MA +1.3% (confirms that it has received in-principle approval from the People's Bank of China to begin formal preparations to set up a domestic bankcard clearing institution in China)
- MYGN +0.9% (submits supplementary premarket approval application to FDA for myChoice CDx with Lynparza in first-line maintenance therapy in advanced ovarian cancer)
Analyst comments:
- CRWD +3.6% (upgraded to Buy from Neutral at DA Davidson)
- JKS +2.8% (upgraded to Outperform from Neutral at CICC)
- SAM +2.5% (upgraded to Outperform from Neutral at Credit Suisse)
- HSBC +1.8% (upgraded to Outperform from Neutral at Credit Suisse)
- FLIR +1.6% (upgraded to Strong Buy from Outperform at Raymond James)
- CORE +1.2% (upgraded to Buy from Hold at Jefferies)
